Aerial BioPharma Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Employees
-
11
- Latest Deal Type
-
M&A
Aerial BioPharma General Information
Description
Operator of a biopharmaceutical agency intended to develop drugs for narcolepsy treatments. The company's biopharmaceutical agency is focused on developing biologics and small molecules for conditions that are affected by processes in the Central Nervous System, enabling healthcare institutions to avail advanced drugs for better treatments.
Contact Information
Website
www.aerialbio.comCorporate Office
- Aerial Center Executive Park
- 9001 Aerial Center Parkway, Suite 110
- Morrisville, NC 27560
- United States
Corporate Office
- Aerial Center Executive Park
- 9001 Aerial Center Parkway, Suite 110
- Morrisville, NC 27560
- United States
Aerial BioPharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 01-Jan-2019 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 20-Feb-2013 | Completed | Startup | |||
| 2. Debt - General | 29-Nov-2012 | $250K | $10.2M | Completed | Startup | |
| 1. Early Stage VC | 11-Oct-2012 | $10M | $10M | Completed | Startup |
Aerial BioPharma Comparisons
Industry
Financing
Details
Aerial BioPharma Competitors (56)
One of Aerial BioPharma’s 56 competitors is Johnson&Johnson Innovative Medicine, a Venture Capital-Backed company based in Raritan, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Johnson&Johnson Innovative Medicine | Venture Capital-Backed | Raritan, NJ | ||||
| IPI Legacy Liquidation | Formerly VC-backed | Seattle, WA | ||||
| Tanabe Pharma | Private Equity-Backed | Osaka, Japan | ||||
| Karyopharm Therapeutics | Formerly VC-backed | Newton, MA | ||||
| Alkermes | Formerly VC-backed | Dublin, Ireland |
Aerial BioPharma Patents
Aerial BioPharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-8859252-B1 | Prostatic acid phosphatase, compositions comprising the same, and methods for producing and/or purifying the same | Inactive | 02-Jan-2014 | ||
| WO-2015102650-A1 | Prostatic acid phosphatase, compositions comprising the same, and methods for producing and/or purifying the same | Inactive | 02-Jan-2014 | ||
| JP-2019147830-A | Treatment of cataplexy | Pending | 13-Mar-2013 | ||
| US-20140275244-A1 | Treatment of cataplexy | Active | 13-Mar-2013 | ||
| WO-2014164969-A1 | Treatment of cataplexy | Inactive | 13-Mar-2013 | C07C271/02 |
Aerial BioPharma Signals
Aerial BioPharma Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 3G Capital | PE/Buyout | Minority | ||
| Solas BioVentures | Venture Capital | Minority | ||
| UNC Health Ventures | Corporate Venture Capital | Minority |
Aerial BioPharma FAQs
-
When was Aerial BioPharma founded?
Aerial BioPharma was founded in 2011.
-
Where is Aerial BioPharma headquartered?
Aerial BioPharma is headquartered in Morrisville, NC.
-
What is the size of Aerial BioPharma?
Aerial BioPharma has 11 total employees.
-
What industry is Aerial BioPharma in?
Aerial BioPharma’s primary industry is Drug Discovery.
-
Is Aerial BioPharma a private or public company?
Aerial BioPharma is a Private company.
-
What is Aerial BioPharma’s current revenue?
The current revenue for Aerial BioPharma is .
-
How much funding has Aerial BioPharma raised over time?
Aerial BioPharma has raised $19.8M.
-
Who are Aerial BioPharma’s investors?
3G Capital, Solas BioVentures, and UNC Health Ventures have invested in Aerial BioPharma.
-
Who are Aerial BioPharma’s competitors?
Johnson&Johnson Innovative Medicine, IPI Legacy Liquidation, Tanabe Pharma, Karyopharm Therapeutics, and Alkermes are some of the 56 competitors of Aerial BioPharma.
-
When was Aerial BioPharma acquired?
Aerial BioPharma was acquired on 01-Jan-2019.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process